Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK)
HKD 15.52
(-0.77%)
HKD 15.52
(-0.77%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -893.36 Million CNY | 19.56% |
| 2022 | -1 Billion CNY | -70.94% |
| 2021 | -543.84 Million CNY | -286.58% |
| 2020 | -160.92 Million CNY | -130.5% |
| 2019 | -69.22 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -95.89 Million CNY | 0.0% |
| 2024 Q1 | -95.89 Million CNY | 50.9% |
| 2023 Q4 | -195.31 Million CNY | 0.0% |
| 2023 FY | - CNY | 19.56% |
| 2023 Q3 | -195.31 Million HKD | 13.11% |
| 2023 Q2 | -224.78 Million CNY | 0.0% |
| 2023 Q1 | -224.78 Million CNY | 26.04% |
| 2022 Q2 | -223.33 Million CNY | 0.0% |
| 2022 Q1 | -223.33 Million CNY | -32.29% |
| 2022 FY | - CNY | -70.94% |
| 2022 Q4 | -303.91 Million CNY | 0.0% |
| 2022 Q3 | -303.91 Million CNY | -36.08% |
| 2021 Q3 | -168.82 Million CNY | -50.16% |
| 2021 FY | - CNY | -286.58% |
| 2021 Q2 | -112.42 Million CNY | 0.0% |
| 2021 Q1 | -112.42 Million CNY | -99.49% |
| 2021 Q4 | -168.82 Million CNY | 0.0% |
| 2020 Q4 | -56.35 Million CNY | 0.0% |
| 2020 Q3 | -56.35 Million CNY | -133.79% |
| 2020 FY | - CNY | -130.5% |
| 2020 Q2 | -24.1 Million CNY | 0.0% |
| 2020 Q1 | -24.1 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 104.43 Million HKD | 955.449% |